Filtros de búsqueda

Lista de obras de

Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide

artículo científico publicado en 2014

Bendamustine in combination with thalidomide and dexamethasone is an effective therapy for myeloma patients with end stage renal disease ⬇️

artículo científico publicado el 21 de junio de 2011

Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience

artículo científico publicado en 2019

Clinical outcomes with fixed-duration therapy (UK real-world data) compared with continuous lenalidomide and low-dose dexamethasone therapy (FIRST trial; MM-020) for transplant-ineligible patients with newly-diagnosed multiple myeloma

scientific article published on 27 November 2019

Correction: Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era

scientific article published on 07 November 2019

DPACE-based chemotherapy in the era of myeloma novel agents: a UK multicentre study

scientific article published on 08 April 2020

In-house age-specific reference ranges for free light chains measured on the SPAPlus® analyser

artículo científico publicado en 2020

Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care

scientific article published on 09 January 2020

Long term outcomes in monoclonal gammopathy of renal significance

artículo científico publicado en 2019

Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era

scientific article published on 23 July 2019

Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration

Mott cells in CD20‐positive myeloma ⬇️

artículo científico publicado el 7 de enero de 2011

Multiple myeloma in the very elderly patient: challenges and solutions

artículo científico publicado en 2016

Pathophysiology and management of monoclonal gammopathy of renal significance

scientific article published on 01 August 2019

Pomalidomide therapy for myeloma ⬇️

artículo científico publicado el 18 de marzo de 2011

Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma

scientific article published on 01 April 2020

Reducing infection-related morbidity and mortality in patients with myeloma

artículo científico publicado en 2019

Relative efficacy of treatment options in transplant-ineligible newly diagnosed multiple myeloma: results from a systematic literature review and network meta-analysis

scientific article published on 11 November 2019

Resource implications of bortezomib therapy in a large UK cohort: An evaluation study

scientific article published on 07 August 2019

Serological normalisation as a surrogate marker for minimal residual disease negativity in multiple myeloma

artículo científico publicado en 2018

Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures

artículo científico publicado en 2019

Time to Redefine Risk-Stratification and Response Criteria in Immunoglobulin Light Chain Amyloidosis?

scientific article published on 07 June 2020

Time to redefine Myeloma

artículo científico publicado en 2015

Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs

scientific article published on 07 June 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda